Safety of selective serotonin reuptake inhibitors in pregnancy AIMS AND METHOD Selective serotonin reuptake inhibi-tors (SSRIs) are recommended by the National Institute for Clinical Excellence as first-line drugs for the treatment of depression, but there is emerging evidence that they might not be entirely safe in pregnancy.We reviewed the literature in this area. RESULTS Some data indicate an association between first-trimester SSRI expo-sure, particularly with paroxetine
OBJECTIVE To summarize the literature on use of the selective serotonin reuptake inhibitor (SSRI) cl...
Objective To review studies conducted to establish the risk of major congenital malformations in wom...
The aim of this review was to critically appraise the existing literature with a particular focus on...
Selective serotonin reuptake inhibitor (SSRI) antidepressants are considered the primary pharmacolog...
OBJECTIVE: The objective of our study was to analyze the efficacy and the safety of SSRIs during pre...
General consensus exists about the need to avoid drug intake as much as possible during pregnancy du...
General consensus exists about the need to avoid drug intake as much as possible during pregnancy du...
Selective serotonin reuptake inhibitors (SSRIs) are increasingly prescribed during pregnancy. The pu...
BACKGROUND: There is ongoing debate about the safety of selective serotonin reuptake inhibitors (SSR...
Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy an...
Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy an...
Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy an...
A literature review was conducted to elucidate the respective reproductive safety profiles of differ...
Depressive disorders in pregnancy are common and generate concerns regarding their treatment. The ef...
Selective serotonin reuptake inhibitors (SSRIs) are considered first-line agents for the treatment o...
OBJECTIVE To summarize the literature on use of the selective serotonin reuptake inhibitor (SSRI) cl...
Objective To review studies conducted to establish the risk of major congenital malformations in wom...
The aim of this review was to critically appraise the existing literature with a particular focus on...
Selective serotonin reuptake inhibitor (SSRI) antidepressants are considered the primary pharmacolog...
OBJECTIVE: The objective of our study was to analyze the efficacy and the safety of SSRIs during pre...
General consensus exists about the need to avoid drug intake as much as possible during pregnancy du...
General consensus exists about the need to avoid drug intake as much as possible during pregnancy du...
Selective serotonin reuptake inhibitors (SSRIs) are increasingly prescribed during pregnancy. The pu...
BACKGROUND: There is ongoing debate about the safety of selective serotonin reuptake inhibitors (SSR...
Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy an...
Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy an...
Studies report that between 6 and 13% of women experience symptoms of depression during pregnancy an...
A literature review was conducted to elucidate the respective reproductive safety profiles of differ...
Depressive disorders in pregnancy are common and generate concerns regarding their treatment. The ef...
Selective serotonin reuptake inhibitors (SSRIs) are considered first-line agents for the treatment o...
OBJECTIVE To summarize the literature on use of the selective serotonin reuptake inhibitor (SSRI) cl...
Objective To review studies conducted to establish the risk of major congenital malformations in wom...
The aim of this review was to critically appraise the existing literature with a particular focus on...